Evidence map›Paper›PMID 37014253›Full record

ArticleMicrobiology spectrum2023

Molecular Diagnosis of Leishmaniasis in Spain: Development and Validation of Ready-To-Use Gel-Form Nested and Real-Time PCRs To Detect

Carmen Chicharro, Javier Nieto, Silvia Miguelañez, Emilia Garcia, Sheila Ortega, Ana Peña, Jose Miguel Rubio, Maria Flores-Chavez

Open access · goldAbstract read
In one paragraph

Article in Microbiology spectrum, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 1 pooled it
6.1field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 1 synthesis or guideline pooled it, 21 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Molecular Detection ofAdvanced biomedical research · 2026
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Carmen ChicharroReference and Research Laboratory for Parasitology, National Centre for Microbiology, Instituto de Salud Carlos III (ISCIII), Madrid, Spain.
Javier NietoReference and Research Laboratory for Parasitology, National Centre for Microbiology, Instituto de Salud Carlos III (ISCIII), Madrid, Spain.
Silvia MiguelañezReference and Research Laboratory for Parasitology, National Centre for Microbiology, Instituto de Salud Carlos III (ISCIII), Madrid, Spain.
Emilia GarciaReference and Research Laboratory for Parasitology, National Centre for Microbiology, Instituto de Salud Carlos III (ISCIII), Madrid, Spain.
Sheila OrtegaReference and Research Laboratory for Parasitology, National Centre for Microbiology, Instituto de Salud Carlos III (ISCIII), Madrid, Spain.
Ana PeñaReference and Research Laboratory for Parasitology, National Centre for Microbiology, Instituto de Salud Carlos III (ISCIII), Madrid, Spain.ORCID 0000-0001-9684-837X
Jose Miguel RubioReference and Research Laboratory for Parasitology, National Centre for Microbiology, Instituto de Salud Carlos III (ISCIII), Madrid, Spain.ORCID 0000-0002-1903-6711
Maria Flores-ChavezReference and Research Laboratory for Parasitology, National Centre for Microbiology, Instituto de Salud Carlos III (ISCIII), Madrid, Spain.ORCID 0000-0003-2597-3100
Instituto de Salud Carlos III · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Leishmaniasis is an endemic parasitic disease in at least 98 countries. In Spain, it is considered a zoonosis caused by Leishmania infantum, with an annual incidence of 0.62 cases/100,000 inhabitants. The predominant clinical manifestations are the cutaneous (CL) and visceral forms (VL), and the diagnosis is performed by parasitological, serological, and molecular tests. At the WHO Collaborating Center for Leishmaniasis (WHOCCLeish), routine diagnostic tests are based on a nested PCR (Ln-PCR), culture, and serological tests. To simplify our PCR protocol, we aimed to develop and validate a ready-to-use nested gel-form PCR (LeishGelPCR) and a duplex real-time PCR (qPCR) that allowed simultaneous detection of

Indexed as

LeishmaniaLeishmaniasisAnimalsDNA, ProtozoanHumansMammalsReal-Time Polymerase Chain ReactionReproducibility of ResultsSensitivity and SpecificitySpainDNA, Protozoangel systemleishmaniasismolecular diagnosisnested PCRparasite loadqPCRsensitivityspecificity

Identifiers

PMID37014253
PMCPMC10269443
OpenAlexW4362522996

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.